FAFN
First Affirmative Financial Network’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1M | Sell |
2,018
-26
| -1% | -$12.9K | 0.62% | 31 |
|
|
2024
Q4 | $1.06M | Sell |
2,044
-5
| -0.2% | -$2.6K | 0.61% | 33 |
|
|
2024
Q3 | $1.27M | Buy |
2,049
+195
| +11% | +$121K | 0.69% | 26 |
|
|
2024
Q2 | $1.03M | Buy |
1,854
+90
| +5% | +$49.8K | 0.71% | 23 |
|
|
2024
Q1 | $1.03M | Sell |
1,764
-10
| -0.6% | -$5.81K | 0.76% | 20 |
|
|
2023
Q4 | $942K | Buy |
1,774
+158
| +10% | +$83.9K | 0.75% | 20 |
|
|
2023
Q3 | $818K | Buy |
1,616
+26
| +2% | +$13.2K | 0.8% | 16 |
|
|
2023
Q2 | $830K | Buy |
1,590
+241
| +18% | +$126K | 0.83% | 16 |
|
|
2023
Q1 | $778K | Buy |
1,349
+98
| +8% | +$56.5K | 0.9% | 11 |
|
|
2022
Q4 | $689K | Sell |
1,251
-119
| -9% | -$65.5K | 0.83% | 14 |
|
|
2022
Q3 | $695K | Sell |
1,370
-92
| -6% | -$46.7K | 0.88% | 16 |
|
|
2022
Q2 | $794K | Sell |
1,462
-36
| -2% | -$19.6K | 0.9% | 20 |
|
|
2022
Q1 | $885K | Buy |
1,498
+60
| +4% | +$35.4K | 0.85% | 22 |
|
|
2021
Q4 | $960K | Sell |
1,438
-42
| -3% | -$28K | 0.88% | 23 |
|
|
2021
Q3 | $845K | Buy |
+1,480
| New | +$845K | 0.87% | 22 |
|